With CC-PCa, we detected ≥1 CTC in 12 out of 15 (86.7%) patients (Figure 4e–h); with CC-EpCAM, we detected ≥1 CTC in 11 out of 15 (73.3%) patients. The gene discussed is EPCAM; the disease is posterior cortical atrophy.